Ultragenyx Pharmaceutical Inc.

BARCLAYS PLC RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

359,148

Value ($000)

8,260

Weight

0.0%

2014 Q1 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	8,260	0.0%	359,148	12/31/2025
2025 Q3	3/31/2026	12,795	0.0%	425,351	9/30/2025
2025 Q2	2/27/2026	6,494	0.0%	178,611	6/30/2025
2025 Q1	3/17/2026	5,174	0.0%	142,881	3/31/2025
2024 Q4	3/19/2026	8,671	0.0%	206,108	12/31/2024
2024 Q3	3/31/2026	4,419	0.0%	79,546	9/30/2024
2024 Q2	3/23/2026	2,586	0.0%	62,913	6/30/2024
2024 Q1	3/24/2026	5,546	0.0%	118,773	3/31/2024
2023 Q4	3/25/2026	7,974	0.0%	166,742	12/31/2023
2023 Q3	3/26/2026	4,303	0.0%	120,693	9/30/2023
2023 Q2	3/30/2026	4,712	0.0%	102,141	6/30/2023
2023 Q1	3/30/2026	3,676	0.0%	91,667	3/31/2023
2022 Q4	3/30/2026	5,772	0.0%	124,587	12/31/2022
2022 Q3	11/3/2022	4,788	0.0%	115,590	9/30/2022
2022 Q2	8/12/2022	1,198	0.0%	20,075	6/30/2022
2022 Q1	5/16/2022	1,423	0.0%	19,602	3/31/2022
2021 Q4	2/14/2022	1,970	0.0%	23,430	12/31/2021
2021 Q3	11/9/2021	425	0.0%	4,715	9/30/2021
2021 Q2	8/13/2021	2,326	0.0%	24,380	6/30/2021
2021 Q1	5/13/2021	8,161	0.0%	71,676	3/31/2021
2020 Q4	2/11/2021	3,257	0.0%	23,524	12/31/2020
2020 Q3	11/12/2020	8,025	0.0%	97,631	9/30/2020
2020 Q2	8/12/2020	2,696	0.0%	34,470	6/30/2020
2020 Q1	5/13/2020	6,742	0.0%	151,772	3/31/2020
2019 Q4	2/10/2020	4,835	0.0%	113,211	12/31/2019
2014 Q1	5/15/2014	9	0.0%	181	3/31/2014